UPDATED ON ON JANUARY, 3, 2023 – 16,49 CET
7 hours after the alarm raised by Gospa News, the newspaper Il Messaggero also notices the problem of the new variant of Omicron…
«There is a new variant of Covid, it’s called Kraken, it has emerged in the United States and is very contagious: it doubles the cases in 7 days. The new mutation, Xbb1.5 (Xbb is the Gryphon variant from which this subvariant descends), could “arouse concern in 2023” also in Europe, after the number of cases in the United States “has doubled in a week”. The alarm was sounded by the US epidemiologist Eric Feigl-Ding, who shared the information on Twitter, arguing “that the new variant is more immunoevasive and more effective in infecting than other subvariants of Omicron”. According to Feigl-Ding, “we have not seen such a rapid growth of cases since the arrival of Omicron Ba.1 a year ago”.»
This is what the Roman newspaper wrote. The kraken is an enormously sized legendary sea monster, usually represented as a gigantic cephalopod resembling an octopus or squid, with tentacles large and long enough to envelop an entire ship.
— Eric Feigl-Ding (@DrEricDing) January 3, 2023
ARTICLE PUBLISHED ON JANUARY, 3, 2023 – 9,35 CET
by Fabio Giuseppe Carlo Carisio
«An intrinsic threat that powerful ePPP viruses (Enhanced Potential Pandemic Pathogens – ed) can escape from high-containment, high-security laboratories and spark an outbreak with much greater lethality than the world just experienced during the Covid-19 pandemic is plausible».
This sentence was written in the letter of five US senators addressed to Director of The Office of Science and Technology Policy in Washington D.C asking the stop of every experiments on SARS viruses and other pathogens, such as Monkeypox, with the use of the viral charge enhancement technique called GOF, Gain of Function.
Gain of Function is a strategic biotechnology used to produce a virus with an increase in viral load in the laboratory. These experiments are called “dual use” because they can have a dual purpose: to find a vaccine and to create a military bacteriological weapon (Dual Use Research of Concern – DURC).
This happened after the last dangerous research.
«For example, on October 14, 2022, when a pre-print article detailed experiments in which Boston University researchers inserted an Omicron SARS-CoV-2 variant gene into a deadlier legacy coronavirus strain, public concerns about potential risks from the experiments quickly followed» recalled the senator, physician and former military officer Roger Wayne Marshall (R-KS) alongside the other four American lawmakers.
This experiment was partially funded by Anthony Fauci.
Now the new Omicron variants have hit China and are also causing concern in the US.
But also in Italy where, despite the low spread of the Covid-19 infection, the Minister of Health Orazio Schillaci has already announced the miruse necessary for an already foreseen increase in cases, perhaps with a crystal ball… May be this pandemic terrorism will be useful to justify the massive purchase of vaccines decided by the government of Prime Minister Giorgia Meloni.
The current surge in Covid-19 infections in China is believed to be driven by the BF.7 sub-variant of Omicron that is circulating in that country. But this isn’t the first time that BF.7 has made news — in October, it started to replace the variants that were then dominant in the United States and several European countries.
At present, the BioNTech-Pfizer mRNA vaccine has only been approved in China for use by German nationals in China, Chinese Ministry of Foreign Affairs spokesperson Mao Ning told a media briefing earlier this month. In exchange, Chinese nationals in Germany have been authorised to take the Chinese vaccines.
“We believe there are discussions going on between the Chinese authorities and some, or at least one, of the mRNA manufacturers around registration of vaccines, and also around the production within China itself, but we’re not privy to those discussions,” said Ryan.
But 3 years later, WHO has still not been able to establish the origin of SARS-Cov-2 which many scientists and recent studies believe was built in the laboratory. As others thought that Omicron original strain was manmade too…
This also happened because WHO director Tedros Adhanom Ghebreyesus, chosen and controlled by world emperor of vaccines Bill Gates, appointed somewhat suspicious scientists in the task forces called to investigate the Covid-19 pandemic virus.
In fact, two researchers with enormous conflicts of interest were chosen as leaders of the research groups: first the Anglo-American zoologist Peter Daszak and then the French virologist Jean-Claude Manuguerra who worked right at the Wuhan Institute of Virology on SARS viruses enhanced in laboratory with the insertion of HIV. The first was financed by Gates and Fauci, through the EcoHealthAlliance of New York, the second by the European Commission chaired by Romano Prodi.
At this point it is legitimate to think that the new variants were not caused only by vaccine resistance as predicted by Geert Vanden Bossche, a vaccine expert and former collaborator of Gates’ NGO Gavi, but that they may have been determined by other genotypes created in the laboratory as feared by US Senators.
Why couldn’t it be the new variant designed by Boston University with partial funding from Fauci through NIAID (National Institute of Allergy and Infectious Diseases)?
Why? To increase the business of the Big Pharma vaccines friends of EU and US politicians, lobbied by Gates, and provide them with a tool for social and health control of the population.
All the links to Gospa News investigations have been added aftermath for the multiple correlations with the topics covered.
COVID-19 Omicron Variant XBB.1.5 More Dominant, Makes Up 40 Percent of New Cases in US: CDC
by Mimi Nguyen Ly – originally published by The Epoch Times
The COVID-19 Omicron XBB.1.5 subvariant nearly doubled in prevalence over the past week, data from the U.S. Centers for Disease Control and Prevention (CDC) showed on Friday, with it now comprising over 40 percent of new cases in the United States.
Specifically, for the week ending Dec. 31, CDC data puts the Omicron XBB.1.5 subvariant as making up 40.5 percent of the total new COVID-19 cases in the country. That figure was 21.7 percent in the week ending Dec. 24.
Meanwhile, subvariants BQ.1 and BQ.1.1 are now at 26.9 percent and 18.3 percent of total new U.S. cases, respectively. Last week, BQ.1.1 was 33.2 percent and BQ.1 was at 24.1 percent of new cases.
The XBB.1.5 subvariant appeared in the United States around late November and has roughly doubled in prevalence every week since, according to CDC data. It accounts for the majority of current COVID-19 cases in the U.S. northeast, at around 75 percent of cases in the New York tri-state area and New England.
Dr. Barbara Mahon, the director of the CDC’s proposed Coronavirus and Other Respiratory Viruses Division, told CBS News that it is projected to be the dominant variant in the U.S. northeast and will increase in prevalence in other regions of the country. However, she said there is “no suggestion at this point that XBB.1.5 is more severe.”
Meanwhile, the BQ.1.1 Omicron subvariant still makes up most cases in the country’s south and west.
XBB ‘Highly Transmissible’: Japanese Researchers
XBB.1.5 descended from the XBB subvariant. The latter was first identified in India in August and quickly became dominant in the country. XBB has also been responsible for the increase in COVID-19 cases in parts of Asia, including Singapore.
In a recent interview with Reuters, Dr. Michael Osterholm, an infectious disease expert at the University of Minnesota, said that “probably the worst variant that the world is facing right now is actually XBB.” He added that seven of the 10 U.S. states where cases and hospitalizations are rising are in the northeast, concurrent with an increase of XBB cases there.
XBB is a recombinant of two subvariants that descended from the Omicron BA.2 subvariant. This means that genetic data from two versions of the virus that descended from BA.2 that had infected a person at the same time, combined during the viral replication process to form the new XBB subvariant.
Japanese researchers said in a paper posted to the preprint server bioRxiv on Dec. 27 that their findings suggest XBB is the “first documented SARS-CoV-2 variant increasing its fitness through recombination rather than single mutations.” The researchers also said their results suggest that XBB is “highly transmissible” and highly resistant to the immunity that was induced by people having had breakthrough infections of the previous Omicron subvariants.
XBB.1.5 Spreading Faster
Yunlong Richard Cao, a Chinese scientist and assistant professor at Peking University, noted that XBB.1.5 has an additional change compared to XBB called the S486P mutation, which gives it a “greatly enhanced” ability to bind to cells through a key receptor called ACE2, or angiotensin-converting enzyme 2.
“The fact that XBB.1.5 showed a much superior growth advantage than XBB.1 suggests that hACE2 [human ACE2] binding affinity does play a heavy role in SARS-CoV-2 spreading. XBB.1 truly suffered from low-hACE2 binding, despite XBB.1’s highest immune evasion capability,” he wrote on Twitter.
Researchers from Columbia University, in a paper published Dec. 13 in the journal Cell, noted that the newly emerged subvariants raise concerns that they may “further compromise the efficacy of current COVID-19 vaccines and monoclonal antibody (mAb) therapeutics.”
“We now report findings that indicate that such concerns are, sadly, justified, especially so for the XBB and XBB.1 subvariants,” they wrote. Part of their findings showed that the new subvariants—Omicron BQ.1, BQ.1.1, XBB, and XBB.1—were able to evade being neutralized by antibodies “from vaccinated individuals with or without prior infection, including persons recently boosted with the new bivalent [booster vaccine].”
“[I]t is alarming that these newly emerged subvariants could further compromise the efficacy of current COVID-19 vaccines and result in a surge of breakthrough infections as well as re-infections,” the scientists wrote. “However, it is important to emphasize that although infections may now be more likely, COVID-19 vaccines have been shown to remain effective at preventing hospitalization and severe disease even against Omicron as well as possibly reducing the risk of [long COVID].”
In the United States, vaccine manufacturers are immune from liability for any adverse reactions unless there’s “willful misconduct” involved.
Health care providers who administer COVID-19 vaccines are required by law to report any serious adverse effects or vaccination administration errors to the Vaccine Adverse Event Reporting System (VAERS), hosted by the U.S. Department of Health and Human Services.
The federal government has a countermeasures program that can compensate eligible persons who suffer serious injury from approved vaccines. But the burden of proof has proven a challenging process.
Other than COVID-19 vaccines, people have taken preventative measures to help boost their immune system and prepared home-based early treatment protocols. A number of protocols have been recommended by various doctors and groups, including the Front Line COVID-19 Critical Care Alliance (FLCCC) and the World Council for Health.
by Mimi Nguyen Ly originally published by The Epoch Times
Fabio is Director and Editor of Gospa News; a Christian Information Journal.
Fabio Giuseppe Carlo Carisio, born on 24/2/1967 in Borgosesia, started working as a reporter when he was only 19 years old in the alpine area of Valsesia, Piedmont, his birth region in Italy. After studying literature and history at the Catholic University of the Sacred Heart in Milan, he became director of the local newspaper Notizia Oggi Vercelli and specialized in judicial reporting.
For about 15 years he is a correspondent from Northern Italy for the Italian newspapers Libero and Il Giornale, also writing important revelations on the Ustica massacre, a report on Freemasonry and organized crime.
With independent investigations, he collaborates with Carabinieri and Guardia di Finanza in important investigations that conclude with the arrest of Camorra entrepreneurs or corrupt politicians.
In July 2018 he found the counter-information web media Gospa News focused on geopolitics, terrorism, Middle East, and military intelligence.
His articles were published on many international media and website as SouthFront, Reseau International, Sputnik Italia, United Nation Association Westminster, Global Research, Kolozeg and more…
His investigations was quoted also by The Gateway Pundit, Tasnim and others
He worked for many years for the magazine Art & Wine as an art critic and curator.